ArticleMedecine tropicale et sante internationale2026
[Rhino-orbito-cerebral mucormycosis: don't overlook direct examination!]
Article in Medecine tropicale et sante internationale, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Rhino-orbito-cerebral mucormycosis is the most common clinical form of mucormycosis. The most common underlying condition associated with this form is diabetes, especially in cases of glycemic imbalance. Observation: This report concerns a 13-year-old girl with type 1 diabetes who was admitted for ketoacidosis. Clinical and radiological examinations revealed progressive orbital cellulitis (Chandler stage II, then V). Despite initiating antibiotic and antifungal treatment, there was no improvement. Surgery was performed to remove necrotic tissue, and mycological and anatomopathological examinations confirmed the diagnosis of mucormycosis. The patient was successfully treated with liposomal amphotericin B for two months. Discussion/Conclusion: Although this infection is rare, it should always be suspected in cases of facial cellulitis, especially in patients with poorly controlled diabetes, to ensure rapid and effective treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.